| Cerus: An Unknown Gem That's Primed for a Boost Michael Shulman submits: Cerus (CERS) is unknown to most, but its technology and main product, the INTERCEPT System, is of importance to more people on the planet than Coca-Cola (KO), Intel (INTC) chips and perhaps Treasury bills.Intercept cleans blood platelets of almost everything, making the supply of platelets donor independent. Today Cerus and the Whittemore Peterson Institute published the results of joint research effort showing INTERCEPT inactivated the XMRV virus. XMRV has been anecdotally linked with Chronic Fatigue Syndrome (CFS). For this reason, the UK, Canada, New Zealand and Australia have banned patients with CFS from giving blood. These results proves the widespread applicability of INTERCEPT to many known and unknown pathogens. Complete results may be presented at the American Association of Blood Banks conference in October.Complete Story » seekingalpha.com |
Provectus reports positive ASCO data on PV-10 in melanoma - Video Illustrates Potential Systemic Benefit from PV-10 Ablation of Cutaneous Melanoma Lesions feedproxy.google.com |
Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update (Business Wire) CAMBRIDGE, Mass.----Ironwood Pharmaceuticals, Inc. today provided an update on its business activities for the second quarter of 2010. us.rd.yahoo.com |
Coverage After Cobra A growing number of the unemployed are exhausting their extended Cobra health-insurance subsidies. There's a slim chance that Congress could extend the subsidy again this fall, but most experts think it's unlikely. online.wsj.com |
Cord Blood America Management Team to Appear on National VoiceAmerica Radio Network [PR Newswire] - Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells to families nationwide and internationally, is pleased to announce that Chairman, CEO and co-founder Matthew Schissler and Dr. us.rd.yahoo.com |